928.
[7] FANG J, SHING Y, WIEDERSCHAIN D, et al. Matrix metalloproteinase2 is required for the switch to the angiogenic phenotype in a tumor model [J]. Proc Natl Acad Sci USA, 2000,97(8):38843889.
[8] HUO N, ICHIKAWA Y, KAMIYAMA M, et al. MMP7(matrilysin) accelerated growth of human umbilical vein endothelial cells [J]. Cancer Lett, 2002,177(1):95.
[9] DERYUGINA E I, BOURDON M A, JUNGWIRTH K, et al. Functional activation of integrin ανβ 3 in tumor cells expressing membranetype 1 matrix metalloproteinase [J]. Int J Cancer, 2000,86(1):1523.
[10] O’REILLY M S, HOLMGREN L, SHING Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma [J]. Cell, 1994,79(2):315328.
[11] NIE Q H, CHENG Y Q, XIE Y M, et al. Inhibiting effect of antisense oligonucleotides phosphorothioate on gene expression of TIMP1 in rat liver fibrosis [J]. World J Gastroenterol, 2001,7(3):363369.
[12] HORNEBECK W，LAMBERT E，PETITFRERE E，et a1. Beneficial and detrimental influences of tissue inhibitor of metalloproteinasel(TIMP1) in tumor propression [J]. Biochimie，2005，87(34)：377383.
[13] ALTADILL A, RODRIGUEZ M, GONZALES L O, et al. Liver expression of matrix metalloproteases and their inhibitors in hepatocellular carcinoma[J]. Dig Liver Dis, 2009,41(10):740748.
[14] MURAWAKI Y, IKUTA Y, KAWASAKI H. Clinical usefulness of serum tissue inhibitor of metalloproteinases(TIMP)2 assay in patients with chronic liver disease in comparison with serum TIMP1 [J]. Clin Chim Acta,1999, 281(12):109120.
[15] 谢玉梅,聂青和,周永兴,等.TIMP1和TIMP2在原发性肝癌生长、浸润及转移中的作用[J].胃肠病学和肝病学杂志,2002,11(3):225228.
[16] LICHTINGHAGEN R, HELMBRECHT T, ARNDT B, et al. Expression pattern of matrix metalloproteinases in human liver[J]. Eur J Clin Chem Clin Biochem, 1995,33(2):6571.
[17] SAKAMOTO Y, MAFUNE K, MORI M, et al. Overexpression of MMP9 correlates with growth of
上一页 [1] [2] [3] [4] [5] [6] [7] 下一页
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文